Aurora Cannabis (TSE:ACB) Shares Up 0.2% – Still a Buy?

Aurora Cannabis Inc. (TSE:ACB) shares traded up 0.2% during trading on Wednesday . The stock traded as high as C$5.37 and last traded at C$5.34. 187,258 shares changed hands during mid-day trading, a decline of 55% from the average session volume of 419,252 shares. The stock had previously closed at C$5.33.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Canaccord Genuity Group dropped their price objective on Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a report on Tuesday, June 30th. BMO Capital Markets raised Aurora Cannabis to a “hold” rating in a report on Wednesday, August 5th. ATB Cormark Capital Markets lowered shares of Aurora Cannabis from an “outperform” rating to a “tender” rating and decreased their target price for the stock from C$6.50 to C$5.60 in a research report on Wednesday, August 19th. Finally, TD lowered their price target on shares of Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating on the stock in a research note on Friday, June 12th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of C$6.20.

Aurora Cannabis Stock Performance

The stock’s 50-day moving average price is C$4.53 and its 200-day moving average price is C$4.63. The company has a debt-to-equity ratio of 4.30, a quick ratio of 2.48 and a current ratio of 5.36. The company has a market capitalization of C$330.85 million, a price-to-earnings ratio of -2.75 and a beta of 0.42.

Aurora Cannabis (TSE:ACB) last announced its quarterly earnings results on Wednesday, August 5th. The company reported C($0.07) EPS for the quarter. Aurora Cannabis had a negative return on equity of 5.21% and a negative net margin of 9.53%.The firm had revenue of C$67.55 million for the quarter. As a group, equities research analysts expect that Aurora Cannabis Inc. will post -0.22 earnings per share for the current year.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.